Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Nuclear Medicine Imaging Agents
1.2 Key Market Segments
1.2.1 Nuclear Medicine Imaging Agents Segment by Type
1.2.2 Nuclear Medicine Imaging Agents Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Nuclear Medicine Imaging Agents Market Overview
2.1 Global Market Overview
2.1.1 Global Nuclear Medicine Imaging Agents Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Nuclear Medicine Imaging Agents Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Nuclear Medicine Imaging Agents Market Competitive Landscape
3.1 Global Nuclear Medicine Imaging Agents Sales by Manufacturers (2019-2024)
3.2 Global Nuclear Medicine Imaging Agents Revenue Market Share by Manufacturers (2019-2024)
3.3 Nuclear Medicine Imaging Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nuclear Medicine Imaging Agents Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Nuclear Medicine Imaging Agents Sales Sites, Area Served, Product Type
3.6 Nuclear Medicine Imaging Agents Market Competitive Situation and Trends
3.6.1 Nuclear Medicine Imaging Agents Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nuclear Medicine Imaging Agents Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Nuclear Medicine Imaging Agents Industry Chain Analysis
4.1 Nuclear Medicine Imaging Agents Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Nuclear Medicine Imaging Agents Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Nuclear Medicine Imaging Agents Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nuclear Medicine Imaging Agents Sales Market Share by Type (2019-2024)
6.3 Global Nuclear Medicine Imaging Agents Market Size Market Share by Type (2019-2024)
6.4 Global Nuclear Medicine Imaging Agents Price by Type (2019-2024)
7 Nuclear Medicine Imaging Agents Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nuclear Medicine Imaging Agents Market Sales by Application (2019-2024)
7.3 Global Nuclear Medicine Imaging Agents Market Size (M USD) by Application (2019-2024)
7.4 Global Nuclear Medicine Imaging Agents Sales Growth Rate by Application (2019-2024)
8 Nuclear Medicine Imaging Agents Market Segmentation by Region
8.1 Global Nuclear Medicine Imaging Agents Sales by Region
8.1.1 Global Nuclear Medicine Imaging Agents Sales by Region
8.1.2 Global Nuclear Medicine Imaging Agents Sales Market Share by Region
8.2 North America
8.2.1 North America Nuclear Medicine Imaging Agents Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nuclear Medicine Imaging Agents Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nuclear Medicine Imaging Agents Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nuclear Medicine Imaging Agents Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nuclear Medicine Imaging Agents Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 GE HealthCare
9.1.1 GE HealthCare Nuclear Medicine Imaging Agents Basic Information
9.1.2 GE HealthCare Nuclear Medicine Imaging Agents Product Overview
9.1.3 GE HealthCare Nuclear Medicine Imaging Agents Product Market Performance
9.1.4 GE HealthCare Business Overview
9.1.5 GE HealthCare Nuclear Medicine Imaging Agents SWOT Analysis
9.1.6 GE HealthCare Recent Developments
9.2 Bracco Diagnostic
9.2.1 Bracco Diagnostic Nuclear Medicine Imaging Agents Basic Information
9.2.2 Bracco Diagnostic Nuclear Medicine Imaging Agents Product Overview
9.2.3 Bracco Diagnostic Nuclear Medicine Imaging Agents Product Market Performance
9.2.4 Bracco Diagnostic Business Overview
9.2.5 Bracco Diagnostic Nuclear Medicine Imaging Agents SWOT Analysis
9.2.6 Bracco Diagnostic Recent Developments
9.3 Guerbet
9.3.1 Guerbet Nuclear Medicine Imaging Agents Basic Information
9.3.2 Guerbet Nuclear Medicine Imaging Agents Product Overview
9.3.3 Guerbet Nuclear Medicine Imaging Agents Product Market Performance
9.3.4 Guerbet Nuclear Medicine Imaging Agents SWOT Analysis
9.3.5 Guerbet Business Overview
9.3.6 Guerbet Recent Developments
9.4 Mallinckrodt
9.4.1 Mallinckrodt Nuclear Medicine Imaging Agents Basic Information
9.4.2 Mallinckrodt Nuclear Medicine Imaging Agents Product Overview
9.4.3 Mallinckrodt Nuclear Medicine Imaging Agents Product Market Performance
9.4.4 Mallinckrodt Business Overview
9.4.5 Mallinckrodt Recent Developments
9.5 Lantheus
9.5.1 Lantheus Nuclear Medicine Imaging Agents Basic Information
9.5.2 Lantheus Nuclear Medicine Imaging Agents Product Overview
9.5.3 Lantheus Nuclear Medicine Imaging Agents Product Market Performance
9.5.4 Lantheus Business Overview
9.5.5 Lantheus Recent Developments
9.6 Yantai Dongcheng
9.6.1 Yantai Dongcheng Nuclear Medicine Imaging Agents Basic Information
9.6.2 Yantai Dongcheng Nuclear Medicine Imaging Agents Product Overview
9.6.3 Yantai Dongcheng Nuclear Medicine Imaging Agents Product Market Performance
9.6.4 Yantai Dongcheng Business Overview
9.6.5 Yantai Dongcheng Recent Developments
9.7 Foshan Rui Diao Pharmaceutical
9.7.1 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Basic Information
9.7.2 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product Overview
9.7.3 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product Market Performance
9.7.4 Foshan Rui Diao Pharmaceutical Business Overview
9.7.5 Foshan Rui Diao Pharmaceutical Recent Developments
9.8 Cardinal Health
9.8.1 Cardinal Health Nuclear Medicine Imaging Agents Basic Information
9.8.2 Cardinal Health Nuclear Medicine Imaging Agents Product Overview
9.8.3 Cardinal Health Nuclear Medicine Imaging Agents Product Market Performance
9.8.4 Cardinal Health Business Overview
9.8.5 Cardinal Health Recent Developments
9.9 Blue Earth Diagnostics
9.9.1 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Basic Information
9.9.2 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product Overview
9.9.3 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product Market Performance
9.9.4 Blue Earth Diagnostics Business Overview
9.9.5 Blue Earth Diagnostics Recent Developments
9.10 Bayer AG
9.10.1 Bayer AG Nuclear Medicine Imaging Agents Basic Information
9.10.2 Bayer AG Nuclear Medicine Imaging Agents Product Overview
9.10.3 Bayer AG Nuclear Medicine Imaging Agents Product Market Performance
9.10.4 Bayer AG Business Overview
9.10.5 Bayer AG Recent Developments
9.11 Abx Advanced Biochemical
9.11.1 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Basic Information
9.11.2 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product Overview
9.11.3 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product Market Performance
9.11.4 Abx Advanced Biochemical Business Overview
9.11.5 Abx Advanced Biochemical Recent Developments
9.12 Eli Lilly and Company
9.12.1 Eli Lilly and Company Nuclear Medicine Imaging Agents Basic Information
9.12.2 Eli Lilly and Company Nuclear Medicine Imaging Agents Product Overview
9.12.3 Eli Lilly and Company Nuclear Medicine Imaging Agents Product Market Performance
9.12.4 Eli Lilly and Company Business Overview
9.12.5 Eli Lilly and Company Recent Developments
9.13 Jubilant Pharma Limited
9.13.1 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Basic Information
9.13.2 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product Overview
9.13.3 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product Market Performance
9.13.4 Jubilant Pharma Limited Business Overview
9.13.5 Jubilant Pharma Limited Recent Developments
9.14 Navidea
9.14.1 Navidea Nuclear Medicine Imaging Agents Basic Information
9.14.2 Navidea Nuclear Medicine Imaging Agents Product Overview
9.14.3 Navidea Nuclear Medicine Imaging Agents Product Market Performance
9.14.4 Navidea Business Overview
9.14.5 Navidea Recent Developments
10 Nuclear Medicine Imaging Agents Market Forecast by Region
10.1 Global Nuclear Medicine Imaging Agents Market Size Forecast
10.2 Global Nuclear Medicine Imaging Agents Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Nuclear Medicine Imaging Agents Market Size Forecast by Country
10.2.3 Asia Pacific Nuclear Medicine Imaging Agents Market Size Forecast by Region
10.2.4 South America Nuclear Medicine Imaging Agents Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Nuclear Medicine Imaging Agents by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Nuclear Medicine Imaging Agents Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Nuclear Medicine Imaging Agents by Type (2025-2030)
11.1.2 Global Nuclear Medicine Imaging Agents Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Nuclear Medicine Imaging Agents by Type (2025-2030)
11.2 Global Nuclear Medicine Imaging Agents Market Forecast by Application (2025-2030)
11.2.1 Global Nuclear Medicine Imaging Agents Sales (K Units) Forecast by Application
11.2.2 Global Nuclear Medicine Imaging Agents Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
